Works matching IS 13524585 AND DT 2018 AND VI 24 AND IP 4

Results: 22

Cytokine signaling in multiple sclerosis: Lost in translation.

Published in:

Multiple Sclerosis Journal, 2018, v. 24, n. 4, p. 432, doi. 10.1177/1352458518763094

By:

Göbel, Kerstin;
Ruck, Tobias;
Meuth, Sven G.

Publication type:

Article

Anxiety is more important than depression in MS – Commentary.

Published in:

Multiple Sclerosis Journal, 2018, v. 24, n. 4, p. 444, doi. 10.1177/1352458518756516

By:

de Jong, Brigit A.;
Uitdehaag, Bernard M. J.

Publication type:

Article

Anxiety is more important than depression in MS – Yes.

Published in:

Multiple Sclerosis Journal, 2018, v. 24, n. 4, p. 440, doi. 10.1177/1352458517751652

By:

Morrow, Sarah A.

Publication type:

Article

How do we measure the epigenome(s)?

Published in:

Multiple Sclerosis Journal, 2018, v. 24, n. 4, p. 446, doi. 10.1177/1352458517750772

By:

Klein, Hans-Ulrich;
De Jager, Philip L.

Publication type:

Article

Do spinal cord lesions matter in patients with clinically isolated syndrome and early MS?

Published in:

2018

By:

Brownlee, Wallace J.

Publication type:

Editorial

Anxiety is more important than depression in MS – No.

Published in:

Multiple Sclerosis Journal, 2018, v. 24, n. 4, p. 442, doi. 10.1177/1352458517748477

By:

Turner, Aaron P.;
Alschuler, Kevin N.

Publication type:

Article

Asymptomatic spinal cord lesions do not predict the time to disability in patients with early multiple sclerosis.

Published in:

Multiple Sclerosis Journal, 2018, v. 24, n. 4, p. 481, doi. 10.1177/1352458517736147

By:

Dekker, Iris;
Sombekke, Madeleine H.;
Witte, Birgit I.;
Geurts, Jeroen J. G.;
Barkhof, Frederik;
Uitdehaag, Bernard M. J.;
Killestein, Joep;
Wattjes, Mike P.

Publication type:

Article

Shifting borders, crossing boundaries: The case of combined central and peripheral demyelination.

Published in:

Multiple Sclerosis Journal, 2018, v. 24, n. 4, p. 550, doi. 10.1177/1352458517726386

By:

Aktas, Orhan

Publication type:

Article

Thrombocytopenia at the time of alemtuzumab infusion in relapsing-remitting multiple sclerosis.

Published in:

2018

By:

Ranganathan, Usha;
Kaunzner, Ulrike;
Foster, Stacyann;
Vartanian, Timothy;
Perumal, Jai S.

Publication type:

Letter to the Editor

Immediate thrombocytopenia at time of alemtuzumab infusion for multiple sclerosis – Not always self-limiting, fully reversible or predictable.

Published in:

2018

By:

Yap, Siew Mei;
McNicholas, Nuala;
Hutchinson, Michael;
McGuigan, Christopher

Publication type:

Letter to the Editor

Acute simultaneous development of brain tumour–like lesion and demyelinating polyneuropathy in a patient with chronic relapsing myelitis.

Published in:

Multiple Sclerosis Journal, 2018, v. 24, n. 4, p. 546, doi. 10.1177/1352458517714610

By:

Puthenparampil, Marco;
Terrin, Alberto;
Federle, Lisa;
Gizzi, Matteo;
Perini, Paola;
Gallo, Paolo

Publication type:

Article

Cerebral rituximab uptake in multiple sclerosis: A <sup>89</sup>Zr-immunoPET pilot study.

Published in:

Multiple Sclerosis Journal, 2018, v. 24, n. 4, p. 543, doi. 10.1177/1352458517704507

By:

Hagens, Marloes H. J.;
Killestein, Joep;
Yaqub, Maqsood M.;
van Dongen, Guus A. M. S.;
Lammertsma, Adriaan A.;
Barkhof, Frederik;
van Berckel, Bart N. M.

Publication type:

Article

Pilot trial of intravenous autologous culture-expanded mesenchymal stem cell transplantation in multiple sclerosis.

Published in:

Multiple Sclerosis Journal, 2018, v. 24, n. 4, p. 501, doi. 10.1177/1352458517703802

By:

Cohen, Jeffrey A.;
Imrey, Peter B.;
Planchon, Sarah M.;
Bermel, Robert A.;
Fisher, Elizabeth;
Fox, Robert J.;
Bar-Or, Amit;
Sharp, Susan L.;
Skaramagas, Thomai T.;
Jagodnik, Patricia;
Karafa, Matt;
Morrison, Shannon;
Reese Koc, Jane;
Gerson, Stanton L.;
Lazarus, Hillard M.

Publication type:

Article

High EDSS can predict risk for upper urinary tract damage in patients with multiple sclerosis.

Published in:

Multiple Sclerosis Journal, 2018, v. 24, n. 4, p. 529, doi. 10.1177/1352458517703801

By:

Ineichen, Benjamin V.;
Schneider, Marc P.;
Hlavica, Martin;
Hagenbuch, Niels;
Linnebank, Michael;
Kessler, Thomas M.

Publication type:

Article

Comparing costs of illness of multiple sclerosis in three different years: A population-based study.

Published in:

Multiple Sclerosis Journal, 2018, v. 24, n. 4, p. 520, doi. 10.1177/1352458517702549

By:

Gyllensten, Hanna;
Wiberg, Michael;
Alexanderson, Kristina;
Friberg, Emilie;
Hillert, Jan;
Tinghög, Petter

Publication type:

Article

Metabolites predict lesion formation and severity in relapsing-remitting multiple sclerosis.

Published in:

Multiple Sclerosis Journal, 2018, v. 24, n. 4, p. 491, doi. 10.1177/1352458517702534

By:

Klauser, Antoine M.;
Wiebenga, Oliver T.;
Eijlers, Anand J. C.;
Schoonheim, Menno M.;
Uitdehaag, Bernard M. J.;
Barkhof, Frederik;
Pouwels, Petra J. W.;
Geurts, Jeroen J. G.

Publication type:

Article

Cognitive impairment in pediatric-onset multiple sclerosis is detected by the Brief International Cognitive Assessment for Multiple Sclerosis and computerized cognitive testing.

Published in:

Multiple Sclerosis Journal, 2018, v. 24, n. 4, p. 512, doi. 10.1177/1352458517701588

By:

Charvet, Leigh E.;
Shaw, Michael;
Frontario, Ariana;
Langdon, Dawn;
Krupp, Lauren B.

Publication type:

Article

Immediate transient thrombocytopenia at the time of alemtuzumab infusion in multiple sclerosis.

Published in:

Multiple Sclerosis Journal, 2018, v. 24, n. 4, p. 540, doi. 10.1177/1352458517699876

By:

Ranganathan, Usha;
Kaunzner, Ulrike;
Foster, Stacyann;
Vartanian, Timothy;
Perumal, Jai S.

Publication type:

Article

Functional network connectivity abnormalities in multiple sclerosis: Correlations with disability and cognitive impairment.

Published in:

Multiple Sclerosis Journal, 2018, v. 24, n. 4, p. 459, doi. 10.1177/1352458517699875

By:

Rocca, Maria A.;
Valsasina, Paola;
Leavitt, Victoria M.;
Rodegher, Mariaemma;
Radaelli, Marta;
Riccitelli, Gianna C.;
Martinelli, Vittorio;
Martinelli-Boneschi, Filippo;
Falini, Andrea;
Comi, Giancarlo;
Filippi, Massimo

Publication type:

Article

Cerebrospinal fluid mtDNA concentration is elevated in multiple sclerosis disease and responds to treatment.

Published in:

Multiple Sclerosis Journal, 2018, v. 24, n. 4, p. 472, doi. 10.1177/1352458517699874

By:

Leurs, Cyra E.;
Podlesniy, Petar;
Trullas, Ramon;
Balk, Lisanne;
Steenwijk, Martijn D.;
Malekzadeh, Arjan;
Piehl, Fredrik;
Uitdehaag, Bernard M. J.;
Killestein, Joep;
van Horssen, Jack;
Teunissen, C. E.

Publication type:

Article

Multiple sclerosis: Serum-derived exosomes express myelin proteins.

Published in:

Multiple Sclerosis Journal, 2018, v. 24, n. 4, p. 449, doi. 10.1177/1352458517696597

By:

Galazka, Grazyna;
Mycko, Marcin P.;
Selmaj, Igor;
Raine, Cedric S.;
Selmaj, Krzysztof W.

Publication type:

Article

The efficacy of teriflunomide in patients who received prior disease-modifying treatments: Subgroup analyses of the teriflunomide phase 3 TEMSO and TOWER studies.

Published in:

Multiple Sclerosis Journal, 2018, v. 24, n. 4, p. 535, doi. 10.1177/1352458517695468

By:

Freedman, Mark S.;
Wolinsky, Jerry S.;
Comi, Giancarlo;
Kappos, Ludwig;
Olsson, Tomas P.;
Miller, Aaron E.;
Thangavelu, Karthinathan;
Benamor, Myriam;
Truffinet, Philippe;
O’Connor, Paul W.

Publication type:

Article